Survivorship Care: What the Research Says About Life After Cancer

A population that did not exist at this scale

Improvements in detection and treatment have produced a large and growing population of people living years or decades beyond a cancer diagnosis. Their clinical needs do not resemble those of patients in active treatment, and the health system has been slower to build for them than to build for the treatment phase itself.

Late effects are the defining clinical problem

Anthracyclines carry cardiotoxic risk that may not manifest for years. Chest radiation raises the risk of second malignancies within the treated field. Platinum agents leave peripheral neuropathy and hearing loss. Endocrine therapy affects bone density. Cognitive changes after chemotherapy are consistently reported by patients and increasingly documented objectively. Each of these requires surveillance that begins after oncology discharge, when responsibility has often shifted without being clearly transferred.

The handoff problem

Survivorship care plans — a structured summary of treatment received, expected late effects, and a surveillance schedule — have been recommended for years. Uptake remains inconsistent, and studies of primary care clinicians repeatedly find low confidence in managing survivors, largely because the specific treatment history is unavailable to them. The gap is less about knowledge than about information transfer.

Psychosocial outcomes are clinical outcomes

Fear of recurrence is among the most commonly reported unmet needs in survivorship research, persisting long after the objective risk has fallen. Financial toxicity, employment disruption, and altered relationships appear consistently in the literature and correlate with quality of life more strongly than some physical measures do. These are measurable outcomes, not soft ones.

What appears to help

Structured exercise has the strongest evidence base of any survivorship intervention, with consistent benefit across fatigue, physical function, and mood, and observational signals for reduced recurrence in some tumour types. Nurse-led survivorship clinics and shared-care models between oncology and primary care have shown improvements in adherence to surveillance without increasing specialist burden.

Why this matters in training

Most survivors will spend the majority of their remaining care in primary care settings. A physician who knows to ask what treatment a patient received, and what that treatment implies twenty years later, is providing oncology care without an oncology clinic. That is where much of the survivorship agenda will actually be delivered.